BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 06, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Feraheme ferumoxytol regulatory update

AMAG said FDA agreed to an updated label for Feraheme ferumoxytol to treat iron deficiency anemia in patients with chronic kidney disease (CKD) that does not include a black box warning. FDA will require the company to include bolded warnings and precautions that describe reported adverse events,...

Read the full 211 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >